Clinical Trials

UNITI Study (H-28485)

The Section of Gastroenterology in the Department of Medicine is currently seeking adults ages 18 years and up to enroll in a study that is testing the safety and efficacy of Ustekinumab in moderate to severe Crohn's disease. Have you tried several treatments for Crohn’s disease but still experiencing symptoms? Qualified participants will receive study-related medication and health assessments at no cost and may be reimbursed for transportation costs.